BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11001260)

  • 1. Outbreak of vancomycin-resistant enterococci in a burn unit.
    Falk PS; Winnike J; Woodmansee C; Desai M; Mayhall CG
    Infect Control Hosp Epidemiol; 2000 Sep; 21(9):575-82. PubMed ID: 11001260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of vancomycin resistant enterococcus in a hematology/oncology unit in a Korean University Hospital, and risk factors related to patients, staff, hospital care and facilities.
    Oh HS; Kim EC; Oh MD; Choe KW
    Scand J Infect Dis; 2004; 36(11-12):790-4. PubMed ID: 15764162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment.
    Hayden MK; Blom DW; Lyle EA; Moore CG; Weinstein RA
    Infect Control Hosp Epidemiol; 2008 Feb; 29(2):149-54. PubMed ID: 18179370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital.
    MacIntyre CR; Empson M; Boardman C; Sindhusake D; Lokan J; Brown GV
    Infect Control Hosp Epidemiol; 2001 Oct; 22(10):624-9. PubMed ID: 11776348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci.
    Drees M; Snydman DR; Schmid CH; Barefoot L; Hansjosten K; Vue PM; Cronin M; Nasraway SA; Golan Y
    Clin Infect Dis; 2008 Mar; 46(5):678-85. PubMed ID: 18230044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of vancomycin-resistant enterococci from a neonatal intensive care unit following an outbreak.
    Ergaz Z; Arad I; Bar-Oz B; Peleg O; Benenson S; Minster N; Moses A; Block C
    J Hosp Infect; 2010 Apr; 74(4):370-6. PubMed ID: 19932526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin-resistant Enterococcus outbreak in a neonatal intensive care unit: epidemiology, molecular analysis and risk factors.
    Iosifidis E; Evdoridou I; Agakidou E; Chochliourou E; Protonotariou E; Karakoula K; Stathis I; Sofianou D; Drossou-Agakidou V; Pournaras S; Roilides E
    Am J Infect Control; 2013 Oct; 41(10):857-61. PubMed ID: 23669299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit.
    Peta M; Carretto E; Barbarini D; Zamperoni A; Carnevale L; Perversi L; Pagani M; Bonora MG; Fontana R; Marone P; Langer M
    Clin Microbiol Infect; 2006 Feb; 12(2):163-9. PubMed ID: 16441455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci.
    Drees M; Snydman DR; Schmid CH; Barefoot L; Hansjosten K; Vue PM; Cronin M; Nasraway SA; Golan Y
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):709-15. PubMed ID: 18631116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].
    Yiş R; Aslan S; Cıtak C; Değirmenci S
    Mikrobiyol Bul; 2011 Oct; 45(4):646-54. PubMed ID: 22090295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci - from disaster to ongoing control.
    Pearman JW
    J Hosp Infect; 2006 May; 63(1):14-26. PubMed ID: 16563562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci.
    Vernon MO; Hayden MK; Trick WE; Hayes RA; Blom DW; Weinstein RA;
    Arch Intern Med; 2006 Feb; 166(3):306-12. PubMed ID: 16476870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of vancomycin-resistant enterococci in the neonatal intensive care unit.
    Singh N; Léger MM; Campbell J; Short B; Campos JM
    Infect Control Hosp Epidemiol; 2005 Jul; 26(7):646-9. PubMed ID: 16092746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.
    Almyroudis NG; Lesse AJ; Hahn T; Samonis G; Hazamy PA; Wongkittiroch K; Wang ES; McCarthy PL; Wetzler M; Segal BH
    Infect Control Hosp Epidemiol; 2011 May; 32(5):490-6. PubMed ID: 21515980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors of vancomycin-resistant enterococcus colonization in burn unit patients.
    Altoparlak U; Koca O; Ozkurt Z; Akcay MN
    Burns; 2011 Feb; 37(1):49-53. PubMed ID: 20926196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control.
    Byers KE; Anglim AM; Anneski CJ; Germanson TP; Gold HS; Durbin LJ; Simonton BM; Farr BM
    Infect Control Hosp Epidemiol; 2001 Mar; 22(3):140-7. PubMed ID: 11310691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.
    Olivier CN; Blake RK; Steed LL; Salgado CD
    Infect Control Hosp Epidemiol; 2008 May; 29(5):404-9. PubMed ID: 18419361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of an outbreak of vancomycin-resistant Enterococcus faecium in a low prevalence university hospital.
    Hwang YS; Brinton BG; Leonard RB; Blue SR; Woods ML; Carroll KC
    J Investig Med; 1998 Dec; 46(9):435-43. PubMed ID: 9861779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
    Salgado CD
    Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyclonal outbreak of vancomycin-resistant Enterococcus faecium in a pediatric oncology department.
    Iosifidis E; Karakoula K; Protonotariou E; Kaperoni M; Matapa E; Pournaras S; Koliouskas D; Sofianou D; Roilides E
    J Pediatr Hematol Oncol; 2012 Oct; 34(7):511-6. PubMed ID: 22627577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.